Chang K, Hanaoka K, Kumada M, Takuwa Y
Department of Cardiovascular Biology, Faculty of Medicine, University of Tokyo, Japan.
J Biol Chem. 1995 Nov 3;270(44):26152-8. doi: 10.1074/jbc.270.44.26152.
The cDNA encoding a novel P2 receptor was isolated from rat aortic smooth muscle cell library and functionally characterized. The cloned P2 receptor exhibits structural features characteristic of the G protein-coupled receptor family and shows 44 and 38% amino acid identity with previously cloned rat P2U and chicken P2Y receptors, respectively. The cloned P2 receptor is functionally coupled to phospholipase C but not to adenylate cyclase in C6 rat glioma cells transfected with the cloned P2 expression vector. The rank order of agonist potency as judged by intracellular Ca2+ mobilization responses is UTP > ADP = 2-methylthioATP > ADP beta S > ATP = ATP gamma S, which is not compatible with any of the previously characterized P2 receptor subtypes. The nonselective P2 antagonists, suramin and reactive blue-2, inhibit nucleotide-induced phospholipase C activation in cells expressing the cloned P2 receptor. The cloned P2 receptor mRNA is abundantly expressed in various rat tissues including lung, stomach, intestine, spleen, mesentery, heart, and, most prominently, aorta. The results indicate that the novel metabotropic P2 receptor has pharmacological characteristics distinct from any of P2 receptor subtypes thus far identified and suggest the existence of a novel regulatory system by extracellular nucleotides of potential significance.
从大鼠主动脉平滑肌细胞文库中分离出编码一种新型P2受体的cDNA并对其进行功能特性分析。克隆的P2受体具有G蛋白偶联受体家族的结构特征,与先前克隆的大鼠P2U受体和鸡P2Y受体分别具有44%和38%的氨基酸同源性。在用克隆的P2表达载体转染的C6大鼠胶质瘤细胞中,克隆的P2受体在功能上与磷脂酶C偶联,但不与腺苷酸环化酶偶联。根据细胞内Ca2+动员反应判断,激动剂效力的顺序为UTP > ADP = 2-甲硫基ATP > ADPβS > ATP = ATPγS,这与任何先前鉴定的P2受体亚型均不相符。非选择性P2拮抗剂苏拉明和活性蓝-2可抑制表达克隆P2受体的细胞中核苷酸诱导的磷脂酶C激活。克隆的P2受体mRNA在大鼠的各种组织中大量表达包括肺、胃、肠、脾、肠系膜、心脏,最显著的是主动脉。结果表明,这种新型的代谢型P2受体具有与迄今鉴定的任何P2受体亚型不同的药理学特性,并提示存在一种具有潜在重要意义的由细胞外核苷酸组成的新型调节系统。